Success Stories: Associate Research Scientist from India Secures EB1A Approval in Neuro Proteomics Despite the RFE Challenge
Client’s Testimonial:
“I’m deeply thankful to the Chen Immigration team for their outstanding support in securing the approval of my I-140 petition. Working with them was a truly reassuring experience. From day one, their professionalism, deep understanding of the EB1A process, and prompt communication gave me confidence every step of the way. They carefully reviewed every detail, provided clear guidance, and were always open to my questions and input. Even when my suggestions needed refinement, they patiently explained the reasoning in both legal and practical terms, which helped me understand the process better and trust it more.
Thanks to their dedication and expertise, my I-140 was successfully approved. I am sincerely grateful for their efforts and highly recommend Chen Immigration to anyone seeking expert help with employment-based immigration.”
On July 7th, 2025, we received another EB1A (Alien of Extraordinary Ability) approval for an Associate Research Scientist in the Field of Neuroproteomics (Approval Notice).
General Field: Neuroproteomics
Position at the Time of Case Filing: Associate Research Scientist
Country of Origin: India
State of Residence at the Time of Filing: Connecticut
Approval Notice Date: July 7th, 2025
Processing Time: 3 months and 13 days (Premium Processing requested)
Case Summary:
North America Immigration Law Group (NAILG) is pleased to announce the successful I-140 EB1A petition approval for our client, an associate research scientist originally from India working in the field of neuroproteomics. Despite receiving a Request for Evidence (RFE), our dedicated team strategically responded, highlighting the client’s remarkable achievements and solidifying her qualification as a leading researcher in neuroproteomics. This petition was filed with the direct premium processing, ensuring expedited adjudication.
Review of Client’s Exceptional Achievements and National Impact
Upon evaluating the client’s contributions, NAILG recognized her substantial influence within the specialized field of neuroproteomics, particularly her pioneering work on advanced mass spectrometry-based proteomics approaches. Her proposed research involves investigating protein-protein interactions in the brain to better understand and diagnose neurodegenerative diseases, including Alzheimer’s. This research directly addresses a critical national priority, given the substantial healthcare and economic impacts of Alzheimer’s disease in the United States. Her innovative methodologies have significantly advanced early disease detection and enhanced understanding of brain function and disease pathology.
Key Accomplishments Reflecting Client’s Global Recognition
NAILG comprehensively documented the following impressive accomplishments to demonstrate the client’s extraordinary ability:
- A robust publication record of 16 peer-reviewed journal articles (4 first-authored and 2 co-first-authored), 15 abstracts (5 first-authored), 1 accepted first-authored abstract, 1 first-authored preprint, and 1 work in submission.
- 326 citations by researchers in at least 42 countries, clearly reflecting the widespread recognition and significant impact of her research within the global scientific community.
- Completed at least 23 peer reviews for leading scientific journals, including the Journal of Proteomics and Scientific Reports, underscoring her established expertise in the field.
- At least 3 top-cited papers, with 1 paper ranking among the top 1% most cited articles and 2 papers ranking among the top 10% most cited articles within the Biology & Biochemistry field for their publication years.
- Secured publications in highly prestigious journals such as Nature Communications, Science Advances, Nature Metabolism, and Alzheimer’s & Dementia: Translational Research & Clinical Interventions, affirming the exceptional quality and importance of her work.
Strong Endorsements from Renowned Experts
The petition included four letters of recommendation, including two independent advisory opinions from globally recognized experts. These letters emphasized her innovative contributions and major influence in neuroproteomics, further validating her international acclaim and the critical impact of her research. One expert stated:
“In summary, [client] has established herself as an invaluable researcher in neuroproteomics, offering transformative insights into brain proteome complexity through path-breaking methodological advancements. By developing sophisticated analytical techniques that bridge technological limitations with biological understanding, [client] provides critical breakthroughs for neurological disorder research. This positions her as a key figure in advancing neuroproteomics and its applications in neuroscience.”
NAILG’s Strategic Petition Preparation Leads to Approval
Thanks to our comprehensive evaluation and strategic preparation of her petition, USCIS approved her I-140 EB1A petition in exactly 3 months and 13 days via the premium processing, despite the issuance of an RFE (Request for Evidence). NAILG’s careful documentation and proactive response to the RFE were pivotal in securing this positive outcome.
We warmly congratulate our client on this significant achievement and look forward to her continued groundbreaking contributions in the field of neuroproteomics, benefiting both U.S. research and global health initiatives.